Leucine-rich repeat kinase 2 mutants I2020T and G2019S exhibit altered kinase inhibitor sensitivity. [electronic resource]
- Biochemical and biophysical research communications Jun 2009
- 255-8 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2009.04.098 doi
Adenosine Triphosphate--chemistry Amino Acid Substitution Humans Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Mutation Parkinson Disease--enzymology Protein Kinase Inhibitors--pharmacology Protein Serine-Threonine Kinases--antagonists & inhibitors